Michael Mackert, PhD
Director of The University of Texas at Austin
Center for Health Communication and Professor in the Stan Richards School of
Advertising & Public Relations and Department of Population Health
| 
Health Communication: Designing Effective
Messages to Promote Behavior Change
Presenter:
Michael
Mackert, PhD
Director of The University of Texas at Austin Center for Health Communication and Professor in the Stan Richards School of Advertising & Public Relations and Department of Population Health
Description:
Better health communication is essential not
just to raising awareness about health issues, but also to promote behavior
change and improved outcomes. This presentation will focus on the development
of more effective health messages which can be used in settings ranging from
interpersonal communication to mass media and digital health campaigns. Issues
related to health literacy and clear communication will be covered, as well as
audience-centered approaches to developing effective messages that are grounded
in more of an advertising perspective Learning Objectives:
Describe
the importance of health literacy as it relates to developing clear and
engaging health messages.
Discuss
the fundamental steps of health campaign message design.
Characterize an audience-centered approach to
developing more effective messages. 1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only):
- AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Licensed Marriage and Family Therapists
- Licensed Professional Counselors
- Licensed Psychologists
- Registered Dietitians
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above.
Suggested Resources:
Batterham RW, Hawkins M, Collins PA, Buchbinder R, Osborne
RH. Health literacy: applying current concepts to improve health services and
reduce health inequalities. Public Health. 2016; 132:3-12.
Mackert M, Mabry-Flynn A, Champlin S, Donovan EE, Pounders K.
Health literacy and health information technology adoption: the potential for a
new digital divide. J Med Internet Res. 2016; 18(10):e264. Free full
text available at https://www.ncbi.nlm.nih.gov/pubmed/27702738
Manganello J, Gerstner G, Pergolino K, Graham Y, Falisi A,
Strogatz D. The relationship of health literacy with use of digital technology
for health information: implications for public health practice. J Public
Health Manag Pract. 2017; 23(4):380-387.
Pope
JP, Pelletier L, Guertin C. Starting off on the best foot: a review of message
framing and message tailoring, and recommendations for the comprehensive
messaging strategy for sustained behavior change. Health Commun. 2018;
33(9):1068-1077. Making
Health Communication Programs Work produced by the National Cancer
Institute
|
Jewel Mullen, MD, MPH
Associate Dean for Health
Equity, Dell Medical School
| .jpg "Partnering for Research, Policy and Equity: Collaboration between State Public Health and Academia (2)")
Partnering for Research, Policy and Equity: Collaboration between State Public Health and Academia Location: Room M100 Presenter:
Jewel Mullen, MD, MPH
Associate Dean for Health Equity, Dell Medical School
Description: The
increasing focus on population health, social determinants and equity, along
with the ongoing call for a health in all policies approach across multiple
sectors, could be the opportunity for state public health to steer population
health improvement at the local, state and federal levels. However, the
prioritization of community-driven approaches to population health improvement
sometimes raises uncertainty about state public health’s contribution to those
efforts. In contending that the leadership of state health agencies remains
essential, this presentation will address the importance of inter and
intra-agency collaboration, academic partnerships, and shared accountability
for health equity. Learning Objectives:
Describe strategies for building collaboration
within and across state agencies.
Explain effective ways to
demonstrate the meaning and value of public health and health equity.
Identify
characteristics of effective academic institution-state health agency
collaboration.
1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only): - AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above. Suggested Resources:
de Montigny JG, Desjardins S, Bouchard L. The fundamentals
of cross-sector collaboration for social change to promote population
health. Glob Health Promot. 2017; e-pub on August 14, 2017.
10.1177/1757975917714036
Gyllstrom E, Gearin K, Nease D Jr, Bekemeier B, Pratt R.
Measuring local public health and primary care collaboration: a
practice-based research approach. J Public Health Manag Pract. 2018;
e-pub on Jun 7, 2018. 10.1097/PHH.0000000000000809.
Lee AF, Quade T, Dwinnells R. Evolution of the academic
health department through public health academic and practice collaborations. J
Public Health Manag Pract. 2014; 20(3):290-6.
Pratt R, Gyllstrom B, Gearin K, Hahn D, VanRaemdonck L,
Peterson K, Baldwin LM. Primary care and public health perspectives on
integration at the local level: a multi-state study. J Am Board Fam Med. 2017;
30(5):601-607. Free full text available at https://www.ncbi.nlm.nih.gov/pubmed/28923812
Towe VL, Leviton L, Chandra A, Sloan JC, Tait M, Orleans T.
Cross-sector collaborations and partnerships: essential ingredients to
help shape health and well-being. Health Aff (Millwood). 2016;
35(11):1964-1969. |
Keila N. Lopez MD, MPH
Assistant Professor, Pediatrics
Director, Transition Medicine
Division of Pediatric Cardiology, Texas Children's Hospital/Baylor College of
Medicine
| 
Leveraging Technology to Reduce Health
Inequities in Pediatric Chronic Disease Location: Room K100 Presenter:
Keila N. Lopez MD, MPH
Assistant Professor, Pediatrics; Director, Transition Medicine, Division of Pediatric Cardiology, Texas Children's Hospital/Baylor College of
Medicine Description:
Disparities
in the medical care provided to the growing chronic disease adolescent survivor
population exist, and involve: - poor
care transition (an age and developmentally appropriate
process, addressing the medical, psychosocial and educational/vocational
aspects of care) from child-centered to adult-centered healthcare, and
- lack
of appropriate transfer of care (the point at which an adult
cardiac provider assumes the medical care of a former pediatric patient).
Finding
innovative ways to improve transition and transfer of care
for pediatric patients with chronic disease is critical to
successful long-term disease management and survival. Please join Keila Lopez MD, MPH, Texas Children's Hospital/Baylor College of Medicine for this thought-provoking discussion.
Learning Objectives:
Describe health inequities during the transition
period for chronic disease adolescents. Examine the evolution of healthcare
technology and adolescent use. Discuss the role of technology on the adolescent
brain. Investigate technologies that may improve health
inequities for chronic disease adolescents.
1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only): - AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above.
Highly Recommended Resources:
TexasYouth2Adult Transition Tool
Texas Youth2Adult is an online tool to help families who have children with special health care needs or other disabilities successfully move from childhood to adulthood. With this tool, families can create personalized accounts and find medical, educational, social, financial, and employment resources and much more. This tool was created by Easter Seals of Greater Houston.
Got Transition
Got Transition resources include the Six Core Elements of Health Care Transition, which define the basic components of health care transition support for providers. These include: establishing a transition policy, tracking progress, administering transition readiness assessments, planning for adult care, transferring care, and integrating into an adult practice.
For Providers: The Six Core Elements of Health Care Transition
Got Transition has also assembled transition planning steps that youth, parents and educators can take to make sure the transition to adult health care goes smoothly. Their website includes an interactive set of frequently asked questions with answers provided by experienced youth, young adults and parents.
For Youth and Families: Got Transition Health Care Transition Resources
Navigate Life Texas website
https://www.navigatelifetexas.org/en
Suggested Resources:
Everitt IK, Gerardin JF, Rodriguez FH, Book WM. Improving
the quality of transition and transfer of care in young adults with congenital
heart disease. Congenit Heart Dis. 2017; 12(3):242-250.
Lopez KN, O'Connor M, King J, et al. Improving transitions
of care for young adults with congenital heart disease: Mobile app development
using formative research. JMIR Form Res. 2018; 2(2): e16. doi:
10.2196/formative.9963. Free full text available at https://www.ncbi.nlm.nih.gov/pubmed/30574573
Twenge JM, Park H. The decline in adult activities among
U.S. adolescents, 1976-2016. Child Dev. 2019; 90(2):638-654. |
Annie (Quratulain) Kizilbash, MD, MPH
Medical Director, Patient Services, Texas Center for Infectious Disease
Elizabeth Foy, RN, BSN
Tuberculosis and Hansen’s Disease Nurse Administrator
Texas
Department of State Health Services
| 
Hansen’s Disease (Leprosy) in Texas: Old World Disease, New World
Resources Location: Room M100
Presenters:
Annie (Quratulain) Kizilbash, MD, MPH
Medical Director, Patient Services, Texas Center for Infectious Disease
Elizabeth Foy, RN, BSN
Tuberculosis and Hansen’s Disease Nurse Administrator, Texas
Department of State Health Services
Description:
Hansen’s Disease
(HD), also known as leprosy, is a disease that many people don’t realize still
exists. However, Texas has reported 101 newly identified cases from 2013-2017,
and patients are treated in clinics supported by the Texas Department of State Health
Services (DSHS). It is a curable disease of the skin and nerves that is caused
by a bacteria carried by animals such as the armadillo. While difficult to
contract, HD is thought to be transmitted by nasal secretions from persons with
untreated disease. You cannot get HD from casual contact such as shaking hands
or sharing a meal, and in fact most people are naturally immune to the disease.
If untreated, HD can cause permanent deformity and disability. The goal of the
DSHS HD Program is to prevent this through early diagnosis and treatment.
This Grand Rounds lecture will focus on the
history and epidemiology of Hansen’s disease, how it’s transmitted and treated
in Texas, and how new research is discovering more about this ancient bacteria. Learning Objectives:
Discuss the incidence of Hansen’s disease (HD) in Texas and
provide a brief epidemiological and historical overview of HD in the US
Describe how Hansen’s disease is contracted, transmitted and
treated
Summarize the services provided by the Texas
DSHS HD clinics in caring for patients with HD.
1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only): - AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above.
Resources Mentioned During the Presentation:
STAR magazine: http://louisianadigitallibrary.org/islandora/object/lsuhsc-p15140coll52%3Acollection
Hansen's Disease in Texas: https://www.dshs.state.tx.us/idcu/disease/hansens.aspx
Suggested Resources:
National
Hansen’s Disease Program
https://www.hrsa.gov/hansens-disease/index.html
Including
“A Manual for the Care of Hansen’s Disease in the United States”
NHDP,
8/2012 which is found here: https://www.dshs.state.tx.us/idcu/disease/hansens/standards.shtm
National
Institute of Allergy and Infectious Disease:
https://www.niaid.nih.gov/diseases-conditions/leprosy-hansens-disease
Leprosy in the 21st Century
Cassandra
White, Carlos Franco-Paredes
Clin Microbiol
Rev. 2015 Jan; 28(1): 80–94. doi: 10.1128/CMR.00079-13
Article PubReader PDF–3.7MCitation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284303/
Guidelines
for the Diagnosis, Treatment and Prevention of Leprosy, WHO 2018
https://apps.who.int/iris/handle/10665/274127
World Health
Organization. Regional Office for South-East Asia. (2018). Guidelines
for the diagnosis, treatment and prevention of leprosy. World Health Organization. Regional Office for
South-East Asia. http://www.who.int/iris/handle/10665/274127. License: CC BY-NC-SA 3.0 IGO
Centers
for Disease Control and Prevention (CDC)
https://www.cdc.gov/leprosy/index.html
|
Lucas
G. Hill, PharmD, BCPS, BCACP
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Director, Operation Naloxone
Mark Kinzly
Texas Overdose Naloxone Initiative
Charles Ray Thibodeaux, BAAS, LCDC
Texas Overdose Naloxone Initiative
Annie Burwell, LBSW
Mobile Outreach Director, Emergency Mental Health, Overdose Response, MM Units, Williamson County Emergency Services
Daniel Sledge, BA, Licensed Paramedic
Lead Paramedic, Williamson County
Mobile Outreach Team
| 
Operation Naloxone: A Harm Reduction First
Model for Addressing the Opioid Crisis Location: Room K100 Presenters:
Lucas
G. Hill, PharmD, BCPS, BCACP
Clinical
Assistant Professor, The University of Texas at Austin College of Pharmacy; Director,
Operation Naloxone
Mark Kinzly
Texas Overdose
Naloxone Initiative
Charles Ray Thibodeaux, BAAS, LCDC
Texas Overdose Naloxone Initiative
Annie Burwell, LBSW
Mobile Outreach Director, Emergency Mental Health, Overdose Response, MM Units,
Williamson County Emergency Services
Daniel Sledge, BA, Licensed Paramedic
Lead Paramedic, Williamson County Mobile
Outreach Team Description:
Recovery from opioid use disorder is complex,
often requiring both medication and behavioral interventions...but people can’t
recover from opioid use disorder if they’re dead. In this session, overdose
prevention experts with diverse clinical backgrounds will describe their
efforts, funded through the Texas Targeted Opioid Response, to keep Texans who
use opioids alive by prioritizing harm reduction. Learning Objectives:
Discuss harm reduction as a key approach to
address the opioid crisis.
Compare national and state-level trends in
opioid-related harm.
Describe the role of naloxone in opioid overdose
prevention.
Examine community paramedic interventions to
connect overdose victims to evidence-based treatment.
1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only): - AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Licensed Chemical Dependency
Counselors
- Licensed
Marriage and Family Therapists
- Licensed
Professional Counselors
- Licensed
Psychologists
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above.
Suggested Resources:
Rzasa LR, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018; 9(1):63-88. Free full text available at https://www.ncbi.nlm.nih.gov/pubmed/29318006
Beletsky L, Burris SC, Kral AH. Closing death's door: action steps to facilitate emergency opioid drug overdose reversal in the United States. A conference report from: Center for Health Law, Policy and Practice; July 21, 2009; Philadelphia, PA. https://ssrn.com/abstract=1437163
Hill LG, Steiker LH, *Mazin L, Kinzly ML. Implementation of a collaborative model for opioid overdose prevention on campus (original research). J Am Coll Health. Published online ahead of print January 7, 2019.
Hill LG, *Sanchez JP, *Laguado SA, Lawson KA. Operation Naloxone: Overdose prevention service learning for student pharmacists (original research). Curr Pharm Teach Learn. 2018;10(10):1348-53.
Evoy KE, Hill LG, Groff L, Mazin L, Carlson C, Reveles KR. Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas (original research). JAMA. 320;18:1934-7.
Mackert M, Pounders K, Brown L, Kirtz S, Hughes Wagner J, Ring D, Hill LG, Wilcox G, Murthy D, Tierney W, Innerarity S, McGlone M, Holleran-Steiker L, DeSalvo K, Bernhardt J, Pretorius K. Development of a health communication campaign to promote the Texas prescription monitoring program (original research). Health Mark Q. Accepted for publication
|
Cal Ham, MD
Centers for Disease Control and Prevention
| 
Superbugs and How to
Prevent Their Spread Location: Room M100 .1.jpg "register now red FINAL(1)")
Presenter:
Cal Ham, MD
Centers for Disease Control and Prevention Description:
This presentation by Dr. Cal Ham from CDC’s
Antimicrobial Resistance Team in the Division of Healthcare Quality Promotion
will focus on highly-resistant superbugs of concern in healthcare settings and
strategies to prevent their spread. Dr.
Ham will discuss the underlying epidemiology of these emerging pathogens
including Carbapenem-resistant Enterobacteriaceae
(CRE), Candida auris, multidrug-resistant
Acinetobacter baumannii, and
carbapenem-resistant Pseudomonas
aeruginosa. He will also describe the key roles healthcare providers and
public health practitioners play in preventing the spread of these organisms,
and the CDC’s novel resistance containment strategy. Learning Objectives:
Describe
the epidemiology, public health importance, and response activities for
selected multi-drug resistant organisms (MDROs).
Describe
CDC’s tiered approach for public health response to contain novel or targeted
MDROs.
Discuss
interventions to prevent spread of superbugs in healthcare including core
infection control practices. 1.5 Continuing Education Credits/Contact Hours Available for the Following (live* event only): - AMA PRA Category 1 CreditsTM
- Continuing Nursing Education
- Certified Health Education Specialists & Master-Certified Health Education Specialists
- Certified in Public Health
- Registered Sanitarians
- Social Workers
A certificate of attendance is available for those not seeking the credits/contact hours listed above.
Suggested Resources:
Centers for Disease Control and Prevention.
Interim Guidance for a Public Health Response to Contain Novel or Targeted
Multidrug-Resistant Organisms (MDROs). https://www.cdc.gov/hai/pdfs/containment/Health-Response-Contain-MDRO-H.pdf
Updated January 2019.
Shams AM, Rose LJ, Edwards
JR, et al. Assessment of the overall and multidrug-resistant organism bioburden
on environmental surfaces in healthcare facilities. Infect Control Hosp
Epidemiol. 2016; 37(12):1426-1432. Free full text available at https://www.ncbi.nlm.nih.gov/pubmed/27619507
Snyder GM, Wright SB. The
epidemiology and prevention of Candida auris. Curr Infect Dis Rep. 2019;
21(6):19.
Trivedi KK, Pollack LA. The
role of public health in antimicrobial stewardship in healthcare. Clin
Infect Dis. 2014; 59 Suppl 3:S101-3.
Woodworth KR, Walters MS,
Weiner LM, et al. Vital signs: containment of novel multidrug-resistant organisms
and resistance mechanisms – United States, 2006-2017. MMWR Morb Mortal Wkly
Rep. 2018 Apr 6;67(13):396-401. Free full text available at https://www.ncbi.nlm.nih.gov/pubmed/29621209
|